Publications by authors named "Ronald Aronson"

Claim this Profile
A
Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Marat Fudim, Renato D Lopes, Daniel M Wojdyla, Roxana Mehran, Muhammad Shahzeb Khan, Ronald Aronson

JACC Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS.
Manasi Tannu, Renato D Lopes, Daniel M Wojdyla, Shaun G Goodman, Ronald Aronson

J Am Coll Cardiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS.
Alexander C Fanaroff, Amit N Vora, Daniel M Wojdyla, Roxana Mehran, Christopher B Granger, Ronald Aronson

Am Heart J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm.
Daniel E Singer, Steven J Atlas, Alan S Go, Steven A Lubitz, David D McManus, Ronald S Aronson

JACC Clin Electrophysiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention.
Renato D Lopes, Steven J Atlas, Alan S Go, Steven A Lubitz, David D McManus, Ronald S Aronson

J Am Coll Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity.
Konstantin A Krychtiuk, Renato D Lopes, Daniel M Wojdyla, Shaun G Goodman, Ronald Aronson

JACC Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial.
Alexander C Fanaroff, Daniel M Wojdyla, Christopher B Granger, Shaun G Goodman, Ronald S Aronson

Circ Cardiovasc Interv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial.
Patricia O Guimarães, Renato D Lopes, Daniel M Wojdyla, John H Alexander, Shaun G Goodman, Ronald Aronson

Am J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach.
Praneeth Jarugula, Sharif Soleman, Hyunmoon Back, Lisa J Christopher, Dara Hawthorne, Ronald Aronson

Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS.
Otavio Berwanger, Daniel M Wojdyla, Alexander C Fanaroff, Andrzej Budaj, Christopher B Granger, Ronald Aronson

J Am Coll Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants.
Vidya Perera, Grigor Abelian, Joseph Luettgen, Ronald Aronson, Danshi Li

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Screening for Atrial Fibrillation in Patients at Moderate-to-High Risk of Stroke　- Potential to Increase the Atrial Fibrillation Detection Rate (SCAN-AF).
Eiichi Watanabe, Naohiko Takahashi, Ronald Aronson, Ako Ohsawa, Yuriko Ishibashi

Circ J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor.
Daniel E Singer, Steven J Atlas, Alan S Go, Renato D Lopes, Steven A Lubitz, Ronald S Aronson

Am Heart J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.
M Cecilia Bahit, Amit N Vora, Zhuokai Li, Daniel M Wojdyla, Laine Thomas, Ronald Aronson

JAMA Cardiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
Ralf E Harskamp, Alexander C Fanaroff, Renato D Lopes, Daniel M Wojdyla, Shaun G Goodman, Ronald Aronson

J Am Coll Cardiol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.
Robert C Welsh, Payam Dehghani, Renato Lopes, Daniel M Wojdyla, Ronald Aronson

Open Heart· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.
Marat Fudim, Daniel M Wojdyla, John H Alexander, Shaun G Goodman, Roxana Mehran, Ronald Aronson

J Am Heart Assoc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Ziad Hijazi, John H Alexander, Zhuokai Li, Daniel M Wojdyla, Roxana Mehran, Ronald Aronson

Circulation· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
Mohammed N Meah, Jennifer Raftis, Simon J Wilson, Vidya Perera, Samira M Garonzik, Ronald Aronson

Arterioscler Thromb Vasc Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
John H Alexander, Daniel Wojdyla, Amit N Vora, Laine Thomas, Christopher B Granger, Ronald Aronson

Circulation· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
Renato D Lopes, Sergio Leonardi, Daniel M Wojdyla, Amit N Vora, Laine Thomas, Ronald Aronson

Circulation· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
Amit N Vora, John H Alexander, Daniel M Wojdyla, Ronald Aronson, Christopher B Granger

Circulation· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Stephan Windecker, Renato D Lopes, Tyler Massaro, Charlotte Jones-Burton, Christopher B Granger, Ronald Aronson

Circulation· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
Renato D Lopes, Gretchen Heizer, Ronald Aronson, Amit N Vora, Tyler Massaro

N Engl J Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis